Physician profile
Mark H Moss
NPI 1639128317
$6,803.20
in general payments reported to CMS, 2019-2025
22 companies · $3,572 in 2025
The $3,572 reported for 2025 was more than what 97% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $27.60 · 2021: $169 · 2022: $562 · 2023: $711 · 2024: $1,469 · 2025: $3,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,415 · Travel and Lodging: $2,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,414.50 |
| Travel and Lodging | $2,336.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,155.82 | 2019-2025 | Hoffmann, Citrefix, Augment Injectable |
| Restor3d, INC. | $1,453.70 | 2025 | |
| Biotronik INC. | $129.43 | 2021 | |
| Trimed, INC. | $120.29 | 2024 | |
| Medtronic, INC. | $111.40 | 2022 | |
| Treace Medical Concepts, INC. | $107.05 | 2023-2025 | |
| Medshape, INC. | $95.48 | 2022 | |
| Medinc of Texas | $94.86 | 2024-2025 | |
| Abbott Laboratories | $68.38 | 2023 | Eterna |
| Abbvie INC. | $67.79 | 2023 | |
| Wright Medical Technology, INC. | $63.69 | 2019 | |
| Smith+Nephew, INC. | $60.09 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Regranex, Collagenase Santyl |
| Encore Medical, Lp | $45.62 | 2022 | |
| Organogenesis INC. | $40.74 | 2022-2025 | Affinity |
| Djo, LLC | $40.29 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $28.77 | 2025 | |
| Kci USA, INC. | $24.42 | 2023 | Activ.A.C., V.A.C. Dermatac |
| Curonix LLC | $21.15 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $20.92 | 2025 | Qutenza |
| Baxter Healthcare | $18.75 | 2019 | |
| Mimedx Group, INC. | $18.16 | 2024 | |
| Depuy Synthes Sales INC. | $16.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.